GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

DERM · Mar 31, 2024

Journey Medical Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001410578-24-000817General Corporate
Debt relative to revenueRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.debt_to_revenue

112.69% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-38.52% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

7.11% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

81.20% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.gross_margin

47.69% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.operating_margin

-77.44% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

60.51% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

10.79% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History16 statesHistory building
Sep 30, 20220/6 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/9 normalizedLevel 3Dec 31, 20230/9 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20246/8 normalizedLevel 3Dec 31, 20247/9 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20256/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 3
Period transition

What moved in the state?

Balance Sheet Leverage Increased
Previous
24.51%
Current
112.69%
Delta
88.19%
Cash Generation Decreased
Previous
8.78%
Current
-38.52%
Delta
-47.30%
Growth Increased
Previous
-15.96%
Current
7.11%
Delta
23.07%
Inventory Pressure Increased
Previous
17.11%
Current
81.20%
Delta
64.09%
Margin Decreased
Previous
55.31%
Current
47.69%
Delta
-7.63%
Profitability Decreased
Previous
-3.47%
Current
-77.44%
Delta
-73.96%
R And D Intensity Increased
Previous
12.64%
Current
60.51%
Delta
47.87%
Sbc Intensity Increased
Previous
4.37%
Current
10.79%
Delta
6.42%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Transitioned To · DERM Fundamental State →Transitioned To · DERM Fundamental State →Transitioned To · DERM BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · DERM CASH_GENERATION_DECREASED →Transitioned To · DERM GROWTH_INCREASED →Transitioned To · DERM INVENTORY_PRESSURE_INCREASED →Transitioned To · DERM MARGIN_DECREASED →Transitioned To · DERM PROFITABILITY_DECREASED →Transitioned To · DERM R_AND_D_INTENSITY_INCREASED →Transitioned To · DERM SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.